{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:48:57Z","timestamp":1784900937191,"version":"3.55.0"},"reference-count":161,"publisher":"Elsevier","isbn-type":[{"value":"9780323910873","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.apha.2022.01.001","type":"book-chapter","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T12:42:38Z","timestamp":1646656958000},"page":"57-94","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacological developments in antihypertensive treatment through nitric oxide\u2014cGMP modulation"],"prefix":"10.1016","member":"78","reference":[{"issue":"3C","key":"10.1016\/bs.apha.2022.01.001_bb0010","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/0002-9343(91)90292-6","article-title":"Interactions between organic nitrates and thiol groups","volume":"91","author":"Abrams","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"13","key":"10.1016\/bs.apha.2022.01.001_bb0015","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2022.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3109\/10715762.2015.1067697","article-title":"The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL\/6 mice","volume":"49","author":"Anvari","year":"2015","journal-title":"Free Radical Research"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0025","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/hep.25938","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent","volume":"56","author":"Aoyama","year":"2012","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/bs.apha.2022.01.001_bb0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0035","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric oxide-cGMP signaling in hypertension: Current and future options for pharmacotherapy","volume":"76","author":"Ataei Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.01.001_bb0040","doi-asserted-by":"crossref","first-page":"2308317","DOI":"10.1155\/2021\/2308317","article-title":"Vascular ageing features caused by selective DNA damage in smooth muscle cell","volume":"2021","author":"Ataei Ataabadi","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI83083","article-title":"Endothelial fluid shear stress sensing in vascular health and disease","volume":"126","author":"Baeyens","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cvr\/cvq081","article-title":"Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension","volume":"87","author":"Bagnost","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.01.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108494","article-title":"Nox1 downregulators: A new class of therapeutics","volume":"152","author":"Barton","year":"2019","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2015.6591","article-title":"Thiol-based redox modulation of soluble guanylyl cyclase, the nitric oxide receptor","volume":"26","author":"Beuve","year":"2017","journal-title":"Antioxidants & Redox Signalling"},{"issue":"8","key":"10.1016\/bs.apha.2022.01.001_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/CS20110679","article-title":"Red wine extract protects against oxidative-stress-induced endothelial senescence","volume":"123","author":"Botden","year":"2012","journal-title":"Clinical Science (London)"},{"issue":"11","key":"10.1016\/bs.apha.2022.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/pharmaceutics12111083","article-title":"Therapeutic approaches to treat mitochondrial diseases: \"One-size-fits-all\" and \"precision medicine\" strategies","volume":"12","author":"Bottani","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/jpet.115.230706","article-title":"A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat","volume":"356","author":"Boustany-Kari","year":"2016","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12872-018-0757-9","article-title":"Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Bredemeier","year":"2018","journal-title":"BMC Cardiovascular Disorders"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.303584","article-title":"Regulation of signal transduction by reactive oxygen species in the cardiovascular system","volume":"116","author":"Brown","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.01.001_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.117.09670","article-title":"Proof-of-principle for a novel class of anti-hypertensives that target the oxidaive activation of protein kinase G 1\u03b1","volume":"70","author":"Burgoyne","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.112.198754","article-title":"cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control","volume":"60","author":"Burgoyne","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.RES.83.3.279","article-title":"Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats","volume":"83","author":"Cernadas","year":"1998","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jcdd5020022","article-title":"Roles of PDE1 in pathological cardiac remodeling and dysfunction","volume":"5","author":"Chen","year":"2018","journal-title":"Journal of Cardiovascular Development and Disease"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbrc.2015.08.066","article-title":"The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE(-)\/(-) mice through inhibiting vascular inflammatory response","volume":"465","author":"Chen","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000513777","article-title":"Study design and baseline characteristics of the CARDINAL trial: A phase 3 study of bardoxolone methyl in patients with Alport syndrome","volume":"52","author":"Chertow","year":"2021","journal-title":"American Journal of Nephrology"},{"issue":"12","key":"10.1016\/bs.apha.2022.01.001_bb0120","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1097\/HJH.0b013e32834d2554","article-title":"Augmented S-nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse aorta: Role of thioredoxin reductase","volume":"29","author":"Choi","year":"2011","journal-title":"Journal of Hypertension"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0125","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FJC.0b013e31822d80a5","article-title":"Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and s-nitrosylation in mouse aorta","volume":"58","author":"Choi","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"14","key":"10.1016\/bs.apha.2022.01.001_bb0130","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1073\/pnas.141136098","article-title":"Catalytic consumption of nitric oxide by 12\/15-lipoxygenase: Inhibition of monocyte soluble guanylate cyclase activation","volume":"98","author":"Coffey","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10053","key":"10.1016\/bs.apha.2022.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: A systematic analysis for the global burden of disease study 2015","volume":"388","author":"Collaborators","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0140","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2005.06.183","article-title":"High lung PDE5: A strong basis for treating pulmonary hypertension with PDE5 inhibitors","volume":"334","author":"Corbin","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/10742484211042706","article-title":"The role of sGC stimulators and activators in heart failure with reduced ejection fraction","volume":"26","author":"Cordwin","year":"2021","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"24","key":"10.1016\/bs.apha.2022.01.001_bb0155","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1074\/jbc.RA120.013802","article-title":"GAPDH delivers heme to soluble guanylyl cyclase","volume":"295","author":"Dai","year":"2020","journal-title":"Journal of Biological Chemistry"},{"issue":"26","key":"10.1016\/bs.apha.2022.01.001_bb0160","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","article-title":"Therapeutic targeting of mitochondrial superoxide in hypertension","volume":"107","author":"Dikalova","year":"2010","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0170","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.117.310933","article-title":"Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension","volume":"121","author":"Dikalova","year":"2017","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","article-title":"Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress","volume":"126","author":"Dikalova","year":"2020","journal-title":"Circulation Research"},{"issue":"Pt 18","key":"10.1016\/bs.apha.2022.01.001_bb0180","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1113\/jphysiol.2011.211219","article-title":"SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans","volume":"589","author":"Donato","year":"2011","journal-title":"Journal of Physiology"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0185","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1113\/EP086988","article-title":"Mitoprotection preserves the renal vasculature in porcine metabolic syndrome","volume":"103","author":"Eirin","year":"2018","journal-title":"Experimental Physiology"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41556-018-0133-0","article-title":"Mitochondrial dynamics in adaptive and maladaptive cellular stress responses","volume":"20","author":"Eisner","year":"2018","journal-title":"Nature Cell Biology"},{"issue":"9","key":"10.1016\/bs.apha.2022.01.001_bb0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cvr\/cvz202","article-title":"Long-lasting blood pressure lowering effects of nitrite are NO-independent and mediated by hydrogen peroxide, persulfides, and oxidation of protein kinase G1alpha redox signalling","volume":"116","author":"Feelisch","year":"2020","journal-title":"Cardiovascular Research"},{"issue":"8","key":"10.1016\/bs.apha.2022.01.001_bb0210","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FJC.0000000000000602","article-title":"Therapeutic drug monitoring to assess drug adherence in assumed resistant hypertension: A comparison with directly observed therapy in 3 nonadherent patients","volume":"72","author":"Feyz","year":"2018","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7625","key":"10.1016\/bs.apha.2022.01.001_bb0220","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature19794","article-title":"Atomic structure of the entire mammalian mitochondrial complex I","volume":"538","author":"Fiedorczuk","year":"2016","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.apha.2022.01.001_bb0225","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1080\/10408398.2017.1422480","article-title":"Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials","volume":"59","author":"Fogacci","year":"2019","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","article-title":"Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"164","author":"Forstermann","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0235","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacological Reviews"},{"issue":"20","key":"10.1016\/bs.apha.2022.01.001_bb0240","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.apha.2022.01.001_bb0245","doi-asserted-by":"crossref","first-page":"H1754","DOI":"10.1152\/ajpheart.00377.2014","article-title":"The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice","volume":"307","author":"Gano","year":"2014","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0250","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.yjmcc.2009.07.025","article-title":"Mechanistic insights into folic acid-dependent vascular protection: Dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: A novel HPLC-based fluorescent assay for DHFR activity","volume":"47","author":"Gao","year":"2009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.111.181644","article-title":"Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: Treatment with folic acid","volume":"59","author":"Gao","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0260","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/HYPERTENSIONAHA.116.07709","article-title":"Activation of SIRT1 attenuates klotho deficiency-induced arterial stiffness and hypertension by enhancing AMP-activated protein kinase activity","volume":"68","author":"Gao","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.bjp.0705581","article-title":"Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK-357,903, in conscious SHR","volume":"141","author":"Gardiner","year":"2004","journal-title":"British Journal of Pharmacology"},{"issue":"23","key":"10.1016\/bs.apha.2022.01.001_bb0270","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/bs.apha.2022.01.001_bb0275","first-page":"E2355","article-title":"Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma","volume":"113","author":"Ghosh","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"10.1016\/bs.apha.2022.01.001_bb0280","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1074\/jbc.M114.559393","article-title":"Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content","volume":"289","author":"Ghosh","year":"2014","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.01.001_bb0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12916-014-0185-3","article-title":"Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials","volume":"12","author":"Giannetta","year":"2014","journal-title":"BMC Medicine"},{"issue":"12","key":"10.1016\/bs.apha.2022.01.001_bb0290","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/HJH.0000000000002189","article-title":"Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension","volume":"37","author":"Gingles","year":"2019","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0295","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0891-5849(95)00034-U","article-title":"The reaction of NO. with O2.- and HO2.: A pulse radiolysis study","volume":"19","author":"Goldstein","year":"1995","journal-title":"Free Radical Biology and Medicine"},{"issue":"20","key":"10.1016\/bs.apha.2022.01.001_bb0300","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group","volume":"338","author":"Goldstein","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"10.1016\/bs.apha.2022.01.001_bb0305","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3390\/ijms21134667","article-title":"Chronic sildenafil treatment improves vasomotor function in a mouse model of accelerated aging","volume":"21","author":"Golshiri","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0310","first-page":"14","article-title":"The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: Focus on phosphodiesterase-1 and soluble guanylate cyclase","volume":"127","author":"Golshiri","year":"2019","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.121.000628","article-title":"Selective PDE1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in ageing animals","volume":"378","author":"Golshiri","year":"2021","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0320","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/HYPERTENSIONAHA.109.130351","article-title":"Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy","volume":"54","author":"Graham","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0325","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000046448.26751.58","article-title":"Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers","volume":"107","author":"Guthikonda","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.01.001_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biomaterials.2016.12.008","article-title":"The 6-chromanol derivate SUL-109 enables prolonged hypothermic storage of adipose tissue-derived stem cells","volume":"119","author":"Hajmousa","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/bs.apha.2022.01.001_bb0335","doi-asserted-by":"crossref","first-page":"26928","DOI":"10.1038\/srep26928","article-title":"The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease","volume":"6","author":"Han","year":"2016","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-019-05062-x","article-title":"An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension","volume":"63","author":"Hanrahan","year":"2020","journal-title":"Diabtologia"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0345","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cpdd.627","article-title":"A randomized, placebo-controlled, multiple-ascending-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the soluble guanylate cyclase stimulator praliciguat in healthy subjects","volume":"8","author":"Hanrahan","year":"2019","journal-title":"Clinical Pharmacology in Drug Development"},{"issue":"22","key":"10.1016\/bs.apha.2022.01.001_bb0350","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM200006013422201","article-title":"Hemodynamic effects of sildenafil in men with severe coronary artery disease","volume":"342","author":"Herrmann","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0355","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/ars.2014.6202","article-title":"Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor","volume":"23","author":"Hirano","year":"2015","journal-title":"Antioxidants & Redox Signalling"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0365","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0021-9258(17)42117-X","article-title":"The reconstituted ADP\/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants","volume":"269","author":"Hoffmann","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0370","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2125.2012.04340.x","article-title":"Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man","volume":"75","author":"Hoffmann","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0375","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","article-title":"Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury","volume":"93","author":"Hong","year":"2018","journal-title":"Kidney International"},{"issue":"6954","key":"10.1016\/bs.apha.2022.01.001_bb0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0385","first-page":"1","article-title":"Beneficial effects of nicotinamide on hypertensive mice with impaired endothelial nitric oxide function","volume":"1","author":"Huynh","year":"2020","journal-title":"Journal of Experimental Nephrology"},{"issue":"22","key":"10.1016\/bs.apha.2022.01.001_bb0390","doi-asserted-by":"crossref","first-page":"21295","DOI":"10.1074\/jbc.M501527200","article-title":"Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools","volume":"280","author":"James","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0395","first-page":"25","article-title":"Myocardial xanthine oxidoreductase activity in hypertensive and hypercholesterolemic rats","volume":"4","author":"Janssen","year":"1993","journal-title":"Cardioscience"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10623320213638","article-title":"Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols","volume":"9","author":"Johnson","year":"2002","journal-title":"Endothelium"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0405","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties","volume":"276","author":"Kelso","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"12, Suppl. 2","key":"10.1016\/bs.apha.2022.01.001_bb0410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjcard.2005.07.011","article-title":"Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: Focus on \u03b1-blocker interactions","volume":"96","author":"Kloner","year":"2005","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/bs.apha.2022.01.001_bb0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-010716-104756","article-title":"Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases","volume":"57","author":"Kokkonen","year":"2017","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103260","article-title":"Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus","volume":"9","author":"Kovamees","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.apha.2022.01.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142081","article-title":"A randomized, placebo-controlled study of SRT2104, a SIRT1 activator, in patients with moderate to severe psoriasis","volume":"10","author":"Krueger","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0430","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: A \"set up\" for vascular disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0435","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1038\/s41598-017-11582-6","article-title":"The novel compound Sul-121 preserves endothelial function and inhibits progression of kidney damage in type 2 diabetes mellitus in mice","volume":"7","author":"Lambooy","year":"2017","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.apha.2022.01.001_bb0440","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"23","key":"10.1016\/bs.apha.2022.01.001_bb0445","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1093\/emboj\/20.23.6591","article-title":"Specific roles of protein-phospholipid interactions in the yeast cytochrome bc1 complex structure","volume":"20","author":"Lange","year":"2001","journal-title":"EMBO Journal"},{"issue":"15","key":"10.1016\/bs.apha.2022.01.001_bb0450","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/bph.13868","article-title":"Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats","volume":"174","author":"Laursen","year":"2017","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0455","first-page":"2876","article-title":"SRT1720, a SIRT1 specific activator, protected H2O2-induced senescent endothelium","volume":"8","author":"Li","year":"2016","journal-title":"American Journal of Translational Research"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0460","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0000000000000587","article-title":"Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension","volume":"33","author":"Li","year":"2015","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0465","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.115.06163","article-title":"Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension","volume":"66","author":"Lopes","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0470","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0475","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/HYPERTENSIONAHA.114.04760","article-title":"Activation of nuclear factor erythroid 2-related factor 2 coordinates dimethylarginine dimethylaminohydrolase\/PPAR-\u03b3\/endothelial nitric oxide synthase pathways that enhance nitric oxide generation in human glomerular endothelial cells","volume":"65","author":"Luo","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0480","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1152\/ajprenal.00376.2016","article-title":"Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction","volume":"312","author":"Manuel","year":"2017","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0485","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphs.2015.03.003","article-title":"Nicorandil directly and cyclic GMP-dependently opens K+ channels in human bypass grafts","volume":"128","author":"Marinko","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/bs.apha.2022.01.001_bb0490","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","article-title":"The role of lipoxygenases in pathophysiology; new insights and future perspectives","volume":"6","author":"Mashima","year":"2015","journal-title":"Redox Biology"},{"issue":"37","key":"10.1016\/bs.apha.2022.01.001_bb0495","doi-asserted-by":"crossref","first-page":"14855","DOI":"10.1073\/pnas.0704329104","article-title":"SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase","volume":"104","author":"Mattagajasingh","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0500","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11906-016-0646-5","article-title":"Role of phosphodiesterase 5 and cyclic GMP in hypertension","volume":"18","author":"Mergia","year":"2016","journal-title":"Current Hypertension Reports"},{"issue":"452","key":"10.1016\/bs.apha.2022.01.001_bb0505","doi-asserted-by":"crossref","first-page":"ra105","DOI":"10.1126\/scisignal.aag0240","article-title":"Obligatory role for GPER in cardiovascular aging and disease","volume":"9","author":"Meyer","year":"2016","journal-title":"Science Signaling"},{"issue":"12","key":"10.1016\/bs.apha.2022.01.001_bb0510","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s00125-009-1550-1","article-title":"The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes","volume":"52","author":"Mollsten","year":"2009","journal-title":"Diabtologia"},{"key":"10.1016\/bs.apha.2022.01.001_bb0515","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f10","article-title":"Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials","volume":"346","author":"Myung","year":"2013","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0520","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1alpha oxidation suppresses antihypertrophic\/antifibrotic effects from PDE5 inhibition but not sGC stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circulation Heart Failure"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0525","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41598-018-36788-0","article-title":"The (R)-enantiomer of the 6-chromanol derivate SUL-121 improves renal graft perfusion via antagonism of the alpha1-adrenoceptor","volume":"9","author":"Nakladal","year":"2019","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0530","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1042\/CS20201412","article-title":"Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO\/sGC\/cGMP pathway","volume":"135","author":"Neves","year":"2021","journal-title":"Clinical Science (London)"},{"key":"10.1016\/bs.apha.2022.01.001_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105235","article-title":"Nox1\/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertension","volume":"161","author":"Nosalski","year":"2020","journal-title":"Pharmacological Research"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0540","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"11","key":"10.1016\/bs.apha.2022.01.001_bb0545","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1","volume":"285","author":"Pacholec","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0550","first-page":"655","article-title":"Acute hypertension: A systematic review and appraisal of guidelines","volume":"14","author":"Pak","year":"2014","journal-title":"The Ochsner Journal"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0555","doi-asserted-by":"crossref","first-page":"H792","DOI":"10.1152\/ajpheart.00953.2010","article-title":"Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme","volume":"300","author":"Pankey","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0560","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2603","article-title":"Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension","volume":"18","author":"Prysyazhna","year":"2012","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0565","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.118.037398","article-title":"Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase","volume":"140","author":"Prysyazhna","year":"2019","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/bs.apha.2022.01.001_bb0570","doi-asserted-by":"crossref","first-page":"22512","DOI":"10.1074\/jbc.M113.525444","article-title":"Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure","volume":"289","author":"Qiao","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0575","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.117.310705","article-title":"Cytochrome b5 reductase 3 modulates soluble guanylate cyclase redox state and cGMP signaling","volume":"121","author":"Rahaman","year":"2017","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0580","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvw107","article-title":"Old dog, new tricks: Novel cardiac targets and stress regulation by protein kinase G","volume":"111","author":"Rainer","year":"2016","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.01.001_bb0585","doi-asserted-by":"crossref","first-page":"9372182","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: A review of their potential for clinical development","volume":"2019","author":"Robledinos-Anton","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0590","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1152\/japplphysiol.00513.2006","article-title":"Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence","volume":"102","author":"Rodriguez-Iturbe","year":"2007","journal-title":"Journal of Applied Physiology (1985)"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0595","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.120.16175","article-title":"Inorganic nitrite supplementation improves endothelial function with aging: Translational evidence for suppression of mitochondria-derived oxidative stress","volume":"77","author":"Rossman","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0600","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.01.001_bb0605","article-title":"Cardiac effects of phosphodiesterase-5 inhibitors: Efficacy and safety","author":"Roy","year":"2021","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0610","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCULATIONAHA.112.101287","article-title":"Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1alpha knock-in mouse","volume":"126","author":"Rudyk","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/hh0202.104108","article-title":"Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation","volume":"90","author":"Rybalkin","year":"2002","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0620","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/emboj\/cdg051","article-title":"PDE5 is converted to an activated state upon cGMP binding to the GAF A domain","volume":"22","author":"Rybalkin","year":"2003","journal-title":"EMBO Journal"},{"issue":"9","key":"10.1016\/bs.apha.2022.01.001_bb0625","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005487","article-title":"Phase 2a clinical trial of mitochondrial protection (Elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis","volume":"10","author":"Saad","year":"2017","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","article-title":"Abnormalities of mitochondrial dynamics in the failing heart: normalization following long-term therapy with elamipretide","volume":"32","author":"Sabbah","year":"2018","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"23","key":"10.1016\/bs.apha.2022.01.001_bb0635","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/01.CIR.102.23.2810","article-title":"Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion","volume":"102","author":"Sage","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0640","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbrc.2009.10.033","article-title":"Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells","volume":"390","author":"Scalera","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0645","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0006-2952(02)01523-X","article-title":"Endothelium-dependent and -independent relaxation and VASP serines 157\/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta","volume":"65","author":"Schafer","year":"2003","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0650","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.109.149542","article-title":"Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1","volume":"55","author":"Schuhmacher","year":"2010","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/bs.apha.2022.01.001_bb0655","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/hc1002.105186","article-title":"Functional and biochemical analysis of endothelial (dys)function and NO\/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment","volume":"105","author":"Schulz","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0660","first-page":"197","article-title":"Reduction of kidney damage by supplementation of vitamins C and E in rats with deoxycorticosterone-salt-induced hypertension","volume":"3","author":"Seifi","year":"2009","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"43","key":"10.1016\/bs.apha.2022.01.001_bb0665","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1074\/jbc.RA118.004363","article-title":"Oxidation of cysteine 117 stimulates constitutive activation of the type Ialpha cGMP-dependent protein kinase","volume":"293","author":"Sheehe","year":"2018","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0670","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.emboj.7601618","article-title":"Structures and physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase","volume":"26","author":"Shinzawa-Itoh","year":"2007","journal-title":"EMBO Journal"},{"issue":"7745","key":"10.1016\/bs.apha.2022.01.001_bb0675","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-019-0947-3","article-title":"Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation","volume":"566","author":"Stanley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.01.001_bb0680","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.jbc.2021.100336","article-title":"Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase","volume":"296","author":"Stuehr","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"issue":"14","key":"10.1016\/bs.apha.2022.01.001_bb0685","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1111\/jcmm.15437","article-title":"Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition","volume":"24","author":"Su","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2022.01.001_bb0690","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13196","article-title":"Sepiapterin reductase gene-disrupted mice suffer from hypertension with fluctuation and bradycardia","volume":"5","author":"Sumi-Ichinose","year":"2017","journal-title":"Physiological Reports"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0695","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cbic.201100809","article-title":"Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat","volume":"13","author":"Surmeli","year":"2012","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0700","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0705","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/ATVBAHA.108.181628","article-title":"Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia","volume":"30","author":"Taylor","year":"2010","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0710","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of vascular nitric oxide and reactive oxygen species and their regulation","volume":"99","author":"Tejero","year":"2019","journal-title":"Physiological Reviews"},{"issue":"5","key":"10.1016\/bs.apha.2022.01.001_bb0715","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajh.2010.27","article-title":"Effects of sepiapterin supplementation and NOS inhibition on glucocorticoid-induced hypertension","volume":"23","author":"Thida","year":"2010","journal-title":"American Journal of Hypertension"},{"issue":"25","key":"10.1016\/bs.apha.2022.01.001_bb0720","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1016\/S0021-9258(18)77211-6","article-title":"Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP","volume":"265","author":"Thomas","year":"1990","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0725","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2012.05.004","article-title":"Novel therapeutic strategies in the management of arterial hypertension","volume":"135","author":"Tousoulis","year":"2012","journal-title":"Pharmacology and Therapeutics"},{"issue":"24","key":"10.1016\/bs.apha.2022.01.001_bb0730","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2174\/0929867322666150625095046","article-title":"Asymmetric dimethylarginine: Clinical significance and novel therapeutic approaches","volume":"22","author":"Tousoulis","year":"2015","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2022.01.001_bb0735","doi-asserted-by":"crossref","first-page":"H18","DOI":"10.1152\/ajpheart.00260.2010","article-title":"Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2","volume":"299","author":"Ungvari","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.01.001_bb0740","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chemphyslip.2018.04.005","article-title":"How cardiolipin peroxidation alters the properties of the inner mitochondrial membrane?","volume":"214","author":"V\u00e4h\u00e4heikkil\u00e4","year":"2018","journal-title":"Chemistry and Physics of Lipids"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0745","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.HYP.0000201445.77125.26","article-title":"Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs","volume":"47","author":"Versari","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0750","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004872-200403000-00016","article-title":"Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice","volume":"22","author":"Virdis","year":"2004","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0755","doi-asserted-by":"crossref","first-page":"R399","DOI":"10.1152\/ajpregu.00122.2017","article-title":"NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion","volume":"314","author":"Wang","year":"2018","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"7","key":"10.1016\/bs.apha.2022.01.001_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181087","article-title":"Generation and phenotypic characterization of Pde1a mutant mice","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/bs.apha.2022.01.001_bb0765","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0770","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.109.149187","article-title":"Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1\/2 is reversed by NADPH oxidase inhibition","volume":"56","author":"Wind","year":"2010","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0775","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2010.00920.x","article-title":"Comparative pharmacology of chemically distinct NADPH oxidase inhibitors","volume":"161","author":"Wind","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2022.01.001_bb0780","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.107.128009","article-title":"Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"325","author":"Wohlfart","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.apha.2022.01.001_bb0785","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000279307","article-title":"Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension","volume":"31","author":"Yaguas","year":"2010","journal-title":"American Journal of Nephrology"},{"issue":"12","key":"10.1016\/bs.apha.2022.01.001_bb0790","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1042\/CS20150605","article-title":"Cyclic nucleotide phosphodiesterase 1 and vascular aging","volume":"129","author":"Yan","year":"2015","journal-title":"Clinical Science (London)"},{"issue":"24","key":"10.1016\/bs.apha.2022.01.001_bb0795","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020673","article-title":"Effect of febuxostat on blood pressure in hyperuricemic patients: A protocol for a systematic review and meta-analysis","volume":"99","author":"Yao","year":"2020","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/bs.apha.2022.01.001_bb0800","doi-asserted-by":"crossref","first-page":"H2243","DOI":"10.1152\/ajpheart.00835.2011","article-title":"Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension","volume":"302","author":"Youn","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0805","first-page":"H669","article-title":"Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome","volume":"314","author":"Yuan","year":"2018","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/bs.apha.2022.01.001_bb0810","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","article-title":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: Novel therapeutic targets","volume":"17","author":"Zhang","year":"2020","journal-title":"Nature Reviews. Cardiology"}],"container-title":["Advances in Pharmacology","New Targets for the Treatment of Hypertension and Associated Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:27:22Z","timestamp":1762360042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358922000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323910873"],"references-count":161,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2022.01.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}